FibriCheck

FibriCheck is a medically certified app (CE Class IIa/FDA approved) capable of the timely detection of heart rhythm disorders, such as atrial fibrillation, using a smartphone or smartwatch. With FibriCheck, users can monitor their heart rhythms wherever and whenever they like, without the need for extra hardware or visits to a healthcare facility. The goal for FibriCheck is to reduce the number of strokes due to atrial fibrillation, and help people with atrial fibrillation to manage the condition. The FibriCheck app can be easily integrated into any wearable, smartwatch or smartphone with PPG sensors, empowering patients and creating new business opportunities for technology companies.
Based in Belgium, FibriCheck is currently used by over 200,000 people in the European Union and the UK, and is prescribed by more than 1,500 physicians. Over 2 million reviewed measurements have been conducted to date, and more than 16,000 heart rhythm disorders have been detected thanks to FibriCheck.
FibriCheck is a registered trademark of Qompium nv. in the EU and US.
For more information, visit www.fibricheck.com.